Additionally, BsAbs targeting immune checkpoint molecules, such as PD-1 or PD-L1, have shown promising results in overcoming immunosuppression and enhancing immune-mediated tumor clearance (6, 7). This evidence concerns the gene CD274 and neoplasm.